Drug Type Cell therapy |
Synonyms SUPLEXA Therapeutic Cells |
Target- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Phase 1 | AU | 28 Apr 2022 | |
Metastatic Solid Tumor | Phase 1 | AU | 28 Apr 2022 | |
Neoplasms | Phase 1 | AU | 28 Apr 2022 |